{
    "title": "As Teva wins US approval for GSK Advair copy, main fight yet to come",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4172534/As-Teva-wins-US-approval-GSK-Advair-copy-main-fight-come.html",
    "date": "2017-01-30",
    "keywords": [
        "advair",
        "approval",
        "copy",
        "product",
        "gmt",
        "ben",
        "market",
        "inhaler",
        "version",
        "asthma",
        "salmeterol",
        "teva",
        "fight",
        "email",
        "hirschlerlondon",
        "jan",
        "battle",
        "medicine",
        "airduo",
        "respiclick",
        "disease",
        "copdteva",
        "monday",
        "year",
        "fluticasone",
        "propionate",
        "dose",
        "cutprice",
        "opportunity",
        "time",
        "blockbuster",
        "patent",
        "protectionfor",
        "gsk",
        "challenge",
        "business",
        "threat",
        "food",
        "drug",
        "administration",
        "mylan",
        "march",
        "hikma",
        "vectura",
        "date",
        "entry",
        "wouldadvair",
        "europe",
        "demand",
        "prescription",
        "conversion",
        "face",
        "unknown",
        "scale",
        "hirschler",
        "editing",
        "fenton"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}